The tudy on the effects and mechanisms of airway-derived exosomal miRNA on airway injury and repair

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2500112393

Enrollment

Unknown

Registered

2025-11-13

Start date

2025-09-30

Completion date

Unknown

Last updated

2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign airway stenosis

Interventions

Contralateral healthy group with tuberculous airway stenosis:None

Tuberculous airway stenosis group:None

Healthy control group:None

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years; 2. Diagnosed with benign airway stenosis within the past 12 months; 3. All participants in the included group have signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Poor compliance and refusal to undergo bronchoscopy; 2. Having contraindications to bronchoscopy; 3. Complicated with severe cardiovascular and cerebrovascular diseases, hematopoietic system diseases, or abnormal mental behaviors; 4. Participating in other clinical trials of drugs or interventional studies.

Design outcomes

Primary

Measure	Time frame
Exosome sequencing;	—

Countries

China

Contacts

Public ContactGou Shuliang

The First Affiliated Hospital of Chongqing Medical University

GUOSL999@sina.com+86 23 8901 1876

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026